A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy

NCT03371550 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Non-small Cell Lung Cancer

Interventions

DRUG: Docetaxel
RADIATION: concomitant radiotherapy
DRUG: Cisplatin

Sponsor

Centre Antoine Lacassagne